About
Monoclonal Antibodies
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibodyTaiwan
Team (28)
Clinical Trials (15)
View allTotal Trials
15
As Lead Sponsor
15
As Collaborator
0
Total Enrollment
349
By Phase
PHASE3: 2PHASE2: 7PHASE1: 6
By Status
COMPLETED: 7UNKNOWN: 3NOT_YET_RECRUITING: 3WITHDRAWN: 2
Clinical Trials Pipeline15 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT03149211Lead Sponsor
To Investigate the Efficacy and Safety of UB-421 Monotherapy in HIV-1 Infected Adults
PHASE3Withdrawn
Started: Apr 1, 2025 · Completed: Dec 31, 2025
NCT03164447Lead Sponsor
UB-421 Combine With Optimized Background Therapy Regimen in Multi-Drug Resistant HIV-1 Infection Patients
PHASE2Unknown
10 participants
Started: Dec 31, 2023 · Completed: May 31, 2024
NCT04620291Lead Sponsor
Study for Evaluation of the Safety, Pharmacokinetics, and Antiviral Activity of UB-421 Subcutaneous Formulation in HIV Infected Adults
PHASE1Not yet recruiting
18 participants
Started: Dec 31, 2023 · Completed: Dec 31, 2025
NCT04175704Lead Sponsor
Evaluating the Safety and Tolerability and Determining the PK and PD of Single Dose UB-221 in Chronic Spontaneous Urticaria
PHASE1Not yet recruiting
32 participants
Started: Dec 30, 2023 · Completed: Jan 30, 2026
NCT04406727Lead Sponsor
UB-421 in Combination With Optimized Background Regimen in Patients With Multi-drug Resistant HIV-1 Infection
PHASE3Not yet recruiting
50 participants
Started: Dec 1, 2023 · Completed: Jun 30, 2026
Locations (1)
Headquarters
Hsinchu, Taiwan
Map
Loading map...